News Companies Natco Pharma Promoter Group Member Sells 45,000 Shares in Open Market TransactionNatco Pharma Promoter Group Member Sells 45,000 Shares in Open Market Transaction
Satya Vani Nannapaneni, a promoter group member of Natco Pharma Limited, sold 45,000 equity shares worth Rs. 4,50,59,895 through open market transactions on March 9, 2026. The sale reduced her shareholding from 3,79,851 shares (0.21%) to 3,34,851 shares (0.19%). The transaction was conducted on NSE and disclosed to stock exchanges on March 11, 2026, in compliance with SEBI regulations. The company's total equity share capital remains at 17,91,09,870 shares of Rs. 2/- each.
*this image is generated using AI for illustrative purposes only.
Natco pharma Limited has received a disclosure from promoter group member Satya Vani Nannapaneni regarding the sale of equity shares in the open market. The transaction, completed on March 9, 2026, involved the sale of 45,000 equity shares of Rs. 2/- each, with the disclosure filed on March 11, 2026, in compliance with SEBI regulations.
Transaction Details
The share sale transaction presents the following key parameters:
| Parameter: | Details |
|---|---|
| Shares Sold: | 45,000 equity shares |
| Share Value: | Rs. 2/- each |
| Transaction Value: | Rs. 4,50,59,895 |
| Transaction Date: | March 9, 2026 |
| Mode of Sale: | Open Market |
| Exchange: | NSE |
Shareholding Changes
The transaction resulted in a reduction of Satya Vani Nannapaneni's stake in the company:
| Shareholding Position: | Before Transaction | After Transaction | Change |
|---|---|---|---|
| Number of Shares: | 3,79,851 | 3,34,851 | -45,000 |
| Percentage Holding: | 0.21% | 0.19% | -0.02% |
| Voting Rights: | 0.21% | 0.19% | -0.02% |
Regulatory Compliance
The disclosure was made in accordance with multiple SEBI regulations:
- Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
- Form C of SEBI (Prohibition of Insider Trading) Regulations, 2015
- Regulation 7(2) read with Regulation 6(2) for continual disclosure requirements
Satya Vani Nannapaneni is identified as a member of the promoter group and is based in Illinois, USA. The disclosure was submitted to both the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited.
Company Share Capital
Natco Pharma Limited's equity structure remains unchanged following this transaction:
| Capital Structure: | Details |
|---|---|
| Total Equity Shares: | 17,91,09,870 |
| Face Value per Share: | Rs. 2/- |
| Diluted Share Capital: | 17,91,09,870 shares |
The transaction represents a routine promoter group share sale conducted through established market mechanisms, with all regulatory disclosure requirements being met within the prescribed timeframes.
Historical Stock Returns for Natco Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.94% | -4.49% | +13.81% | +10.86% | +21.94% | +15.85% |
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
